ScopinastAlternative Names: Escopinast; KA 398; Scopinast fumarate
Latest Information Update: 05 Feb 2001
At a glance
- Originator Dr. Willmar Schwabe Group
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Coumarins
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Asthma; Seasonal allergic rhinitis